Investment strategy

[ad_1] Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on…

[ad_1] Evercore ISI initiated coverage of Aclaris Therapeutics , a clinical stage biotech working on immunology and inflammation drugs, at…

[ad_1] Danaher (DHR) is a day away from shedding its environmental-and-applied solutions segment, and the Club holding’s ability to deliver…